ADVFN Logo ADVFN

Não encontramos resultados para:
Verifique se escreveu corretamente ou tente ampliar sua busca.

Tendências Agora

Rankings

Parece que você não está logado.
Clique no botão abaixo para fazer login e ver seu histórico recente.

Cadastre-se

Já é membro? Faça login

Moneta Markets

Abrir Conta

Moneta Markets
Dados
Notícias
Ferramentas
Mercados
Comunidade

Hot Features

Follow Feed

Conecte-se com traders e investidores em nossa comunidade Follow Feed.

Fluxo de Opções

Explore dados abrangentes de opções e utilize filtros avançados com Fluxo de Opções.

Monitor

Organize e monitore sua lista de ações e ativos com o Monitor.
Entrar Premium IconPremium Help Menu
Índice Bovespa
122.641,30
0,25%
S&P 500
5.477,90
0,16%
US Dollar vs BRL
5,5238
0,00%
Bitcoin
60.954,18
0,23%
Brent Oil
84,195
-0,33%
Registration Strip Icon for tools Aumente o nível de sua negociação com nossas ferramentas poderosas e insights em tempo real, tudo em um só lugar.
Cadastre-se
  1. Início
  2. Investir
  3. Ações
  4. EUA
  5. NASDAQ
  6. GT Biopharma Inc (GTBP)

  7. GT Biopharma Inc (GTBP) Notícias

GTBP

GT Biopharma (GTBP)

GT Biopharma Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:GTBP
DataHoraFonteTítuloCódigoCompanhia
17/06/202417:26Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:GTBPGT Biopharma Inc
13/06/202417:14Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNASDAQ:GTBPGT Biopharma Inc
07/06/202418:25Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:GTBPGT Biopharma Inc
23/05/202421:31Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:GTBPGT Biopharma Inc
23/05/202407:04Edgar (US Regulatory)Form 424B5 - Prospectus [Rule 424(b)(5)]NASDAQ:GTBPGT Biopharma Inc
15/05/202418:00Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:GTBPGT Biopharma Inc
06/11/202319:21Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:GTBPGT Biopharma Inc
27/10/202318:23Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:GTBPGT Biopharma Inc
19/09/202312:56Edgar (US Regulatory)Form SC 13G - Statement of acquisition of beneficial ownership by individualsNASDAQ:GTBPGT Biopharma Inc
15/08/202320:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:GTBPGT Biopharma Inc
05/05/202318:30Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:GTBPGT Biopharma Inc
05/05/202318:29Edgar (US Regulatory)Revised Proxy Soliciting Materials (definitive) (defr14a)NASDAQ:GTBPGT Biopharma Inc
04/05/202320:15Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:GTBPGT Biopharma Inc
04/05/202310:06Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:GTBPGT Biopharma Inc
11/04/202320:00Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:GTBPGT Biopharma Inc
30/03/202318:02Edgar (US Regulatory)Annual Report (10-k)NASDAQ:GTBPGT Biopharma Inc
14/02/202314:55Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:GTBPGT Biopharma Inc
04/01/202308:02Edgar (US Regulatory)Prospectus Filed Pursuant to Rule 424(b)(5) (424b5)NASDAQ:GTBPGT Biopharma Inc
21/10/202207:04Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:GTBPGT Biopharma Inc
13/09/202207:20TipRanksAnalysts Offer Insights on Healthcare Companies: Dynavax (DVAX), Ascendis Pharma (ASND) and GT Biopharma (GTBP)NASDAQ:GTBPGT Biopharma Inc
17/08/202218:01Edgar (US Regulatory)Amended Current Report Filing (8-k/a)NASDAQ:GTBPGT Biopharma Inc
15/08/202210:38Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:GTBPGT Biopharma Inc
25/07/202217:36Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:GTBPGT Biopharma Inc
19/05/202212:45TipRanksB.Riley Financial Thinks GT Biopharma’s Stock is Going to RecoverNASDAQ:GTBPGT Biopharma Inc
29/04/202218:21Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:GTBPGT Biopharma Inc
19/04/202218:31Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:GTBPGT Biopharma Inc
12/04/202207:26TipRanksGT Biopharma (GTBP) Receives a Buy from H.C. WainwrightNASDAQ:GTBPGT Biopharma Inc
11/03/202208:28TipRanksH.C. Wainwright Sticks to Its Buy Rating for GT Biopharma (GTBP)NASDAQ:GTBPGT Biopharma Inc
03/03/202208:07Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:GTBPGT Biopharma Inc
29/12/202119:26Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:GTBPGT Biopharma Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:GTBP

Seu Histórico Recente

BOV
IBOV
Índice Bovespa
BOV
PRIO3
PETRORIO ON
BOV
OIBR3
OI ON
BOV
TELB4
TELEBRAS PN
BOV
DASA3
DASA ON
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Brasil
Empresa
Negócios
Popular
Obter o aplicativo
App Store
Google Play

Suporte: (11) 4950 5808 | suporte@advfn.com.br

Ao acessar os serviços da ADVFN você estará de acordo com os Termos e Condições

© 2024 ADVFN PLC - Todos os direitos reservados